DK0593562T3 - Topisk præparat indeholdende penciclovir - Google Patents

Topisk præparat indeholdende penciclovir

Info

Publication number
DK0593562T3
DK0593562T3 DK92914132T DK92914132T DK0593562T3 DK 0593562 T3 DK0593562 T3 DK 0593562T3 DK 92914132 T DK92914132 T DK 92914132T DK 92914132 T DK92914132 T DK 92914132T DK 0593562 T3 DK0593562 T3 DK 0593562T3
Authority
DK
Denmark
Prior art keywords
preparation containing
topical preparation
penciclovir
containing penciclovir
cetomacrogol
Prior art date
Application number
DK92914132T
Other languages
English (en)
Inventor
John Goodall Alan
Hazel-Ann Griffiths
Joshua Oduro-Yeboah
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK0593562T3 publication Critical patent/DK0593562T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
DK92914132T 1991-07-11 1992-07-03 Topisk præparat indeholdende penciclovir DK0593562T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919114939A GB9114939D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation
PCT/GB1992/001208 WO1993000905A1 (en) 1991-07-11 1992-07-03 Tropical composition containing penciclovir

Publications (1)

Publication Number Publication Date
DK0593562T3 true DK0593562T3 (da) 1999-09-27

Family

ID=10698164

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92914132T DK0593562T3 (da) 1991-07-11 1992-07-03 Topisk præparat indeholdende penciclovir

Country Status (18)

Country Link
EP (1) EP0593562B1 (da)
JP (1) JP2865867B2 (da)
KR (1) KR100245016B1 (da)
AT (1) ATE177638T1 (da)
AU (2) AU2230792A (da)
CA (1) CA2113080C (da)
DE (1) DE69228686T2 (da)
DK (1) DK0593562T3 (da)
ES (1) ES2128353T3 (da)
GB (1) GB9114939D0 (da)
GR (1) GR3029886T3 (da)
IE (1) IE922263A1 (da)
MX (1) MX9204030A (da)
NZ (1) NZ243490A (da)
PT (1) PT100670B (da)
TW (1) TW328049B (da)
WO (1) WO1993000905A1 (da)
ZA (1) ZA925130B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326177D0 (en) * 1993-12-22 1994-02-23 Smithkline Beecham Plc Pharmaceuticals
US6124304A (en) * 1993-10-05 2000-09-26 Smithkline Beecham Plc Penciclovir for the treatment of zoster associated pain
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
CN109481674A (zh) * 2018-11-14 2019-03-19 大连亚维药业有限公司 一种生物无菌乳膏药物的生产方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
AU698847B2 (en) 1998-11-12
HK1012242A1 (en) 1999-07-30
ES2128353T3 (es) 1999-05-16
KR100245016B1 (ko) 2000-03-02
TW328049B (en) 1998-03-11
GR3029886T3 (en) 1999-07-30
EP0593562B1 (en) 1999-03-17
JP2865867B2 (ja) 1999-03-08
DE69228686D1 (de) 1999-04-22
AU2230792A (en) 1993-02-11
NZ243490A (en) 1995-03-28
PT100670B (pt) 1999-07-30
CA2113080A1 (en) 1993-01-21
PT100670A (pt) 1993-10-29
AU4040195A (en) 1996-02-22
CA2113080C (en) 2003-02-25
ATE177638T1 (de) 1999-04-15
MX9204030A (es) 1993-02-01
ZA925130B (en) 1993-05-05
JPH06508845A (ja) 1994-10-06
DE69228686T2 (de) 1999-09-09
GB9114939D0 (en) 1991-08-28
IE922263A1 (en) 1993-01-13
WO1993000905A1 (en) 1993-01-21
EP0593562A1 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
BG101118A (en) Therapeutical compounds
NO992638L (no) Gelformulering for topisk legemiddellevering
CA2293470A1 (en) Benzimidazole derivatives
ES2179040T3 (es) Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b.
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
NO943837L (no) Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, fremstilling av slike derivater, samt farmasöytiske preparater
MX9200728A (es) Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel.
ES2044843T3 (es) Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos.
ZA925130B (en) Pharmaceutical formulation.
MY110074A (en) Pharmacuetical formulation.
DK0437225T3 (da) Topiske præparater
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
KR910004186A (ko) 제약학적 배합물
DE69902925D1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen
SE8802257D0 (sv) Antimikrobiell komposition
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
IT1242000B (it) Impiego di sali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana.
IT1254361B (it) Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose.
ITGE940025A0 (it) Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi.
BR9810930A (pt) Composições farmacêuticas de arglabina e derivados de arglabina
ITRM940505A0 (it) "agente attivo per il trattamento di infezioni croniche da immunodepressione e per contrastare lo sviluppo di tumori favoriti da immunodepressione".
FI941707L (fi) Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan
MX9203715A (es) Preparciones para el tratamiento del tejido aloinjertado.